1 l), conjunctival injection and chemosis, and periorbital edema.

2  due to the observed presence of substantial periorbital edema.

3 sures and fundus findings of 4 patients with periorbital edema.

4 he scientific literature of notable cases of periorbital edema.

5 nts were lid (11.8% study, 1.1% control) and periorbital edema (12.9%, 1.1%).

6  decontamination, but 5 patients developed a periorbital edema, 2 experienced radiating neuropathic p

7 e most frequent adverse events observed were periorbital edema (69%), anemia (55%), diarrhea (45%), t

8 change in hair color, nausea, dysgeusia, and periorbital edema; adverse events rarely led to disconti

9                  Examination revealed marked periorbital edema and hematoma, ptosis, ocular movements

10 ed as persons presenting with myalgia and/or periorbital edema and Trichinella-specific immunoglobuli

11 individuals characterized by fever, myalgia, periorbital edema, and fatigue.

12 ated with elevated intraocular pressure from periorbital edema, direct compression on the eye, and in

13 sent to the clinician with similar findings: periorbital edema, erythema, proptosis, and pain.

14                           PURPOSE OF REVIEW: Periorbital edema is a common problem that deserves scru

15 ospect of triaging, diagnosing, and treating periorbital edema less daunting.

16 most common ocular manifestation, comprising periorbital edema (n = 83, 40.7%), orbital myositis (n =

17 rlier resolution of inflammation in terms of periorbital edema (P = .002 at day 7), conjunctival chem

18  hyperthyroidism, resulting in exophthalmos, periorbital edema, pain, double vision, optic neuropathy